Exhibit 99.2

MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE — RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
Restated for Discontinued Operations
(In thousands)
(Unaudited)

     The following table reconciles Adjusted EBITDA with MedCath’s income (loss) from continuing operations as derived from MedCath’s consolidated statements of operations:

	FY2004			FY2005															FY2006
	YR			Q1			Q2			Q3			Q4			YR			Q1			Q2			Q3
Income (loss) from continuing operations	$	(1,467	)	$	1,664		$	2,628		$	2,634		$	(550	)	$	6,376		$	(1,337	)	$	(2,641	)	$	5,349
Add:
Income tax (benefit) expense		(1,302	)		1,107			1,755			1,952			(101	)		4,713			(890	)		(1,766	)		3,649
Minority interest share of earnings of consolidated subsidiaries		6,879			3,999			4,402			3,956			3,611			15,968			2,818			4,790			4,742
Equity in net earnings of unconsolidated affiliates		(3,540	)		(769	)		(886	)		(899	)		(802	)		(3,356	)		(1,065	)		(1,410	)		(1,408	)
Interest and other income, net		(854	)		(389	)		(613	)		(868	)		(1,175	)		(3,045	)		(1,404	)		(1,367	)		(2,977	)
Interest expense		25,879			7,876			7,813			8,440			8,705			32,834			9,059			8,899			7,870
Loss on debt refinancing		5,072			—			—			—			—			—			—			—			—
Impairments of long-lived assets and goodwill		7,227			—			—			—			2,662			2,662			—			—			451
Loss (gain) on disposal of property, equipment and other assets		89			1			55			148			(824	)		(620	)		97			(38	)		(296	)
Amortization		1,160			290			290			290			290			1,160			252			252			252
Depreciation		38,975			9,243			8,937			9,034			10,379			37,593			9,171			9,264			9,366
Share-based compensation expense		—			—			—			—			1,468			1,468			418			10,206			1,756
Adjusted EBITDA	$	78,118		$	23,022		$	24,381		$	24,687		$	23,663		$	95,753		$	17,119		$	26,189		$	28,754
Add:
Pre-opening expenses		5,103			—			—			—			—			—			—			—			—
Adjusted EBITDA, before pre-opening expenses	$	83,221		$	23,022		$	24,381		$	24,687		$	23,663		$	95,753		$	17,119		$	26,189		$	28,754